Fully Human Antagonistic Antibodies Against CCR4 Potently Inhibit Cell Signaling and Chemotaxis

PLoS ONE - United States
doi 10.1371/journal.pone.0103776
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Fully Human Single-Domain Antibodies Against SARS-CoV-2

2020English

Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways

Frontiers in Immunology
AllergyImmunology
2012English

Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection Through Their Antagonistic Effects on CCR5

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Antibodies Against Dengue Virus E Protein Peptide Bind to Human Plasminogen and Inhibit Plasmin Activity

Clinical and Experimental Immunology
AllergyImmunology
1997English

Class I Histone Deacetylase-Selective Novel Synthetic Inhibitors Potently Inhibit Human Tumor Proliferation

Clinical Cancer Research
Cancer ResearchOncology
2004English

Umbralisib and Carfilzomib Potently Inhibit Cap Dependent Translation in Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Monoclonal Antibodies Raised Against 167–180 Aa Sequence of Human Carbonic Anhydrase XII Inhibit Its Enzymatic Activity

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2014English

TGFβ1 Antagonistic Peptides Inhibit TGFβ1-dependent Angiogenesis

Biochemical Pharmacology
BiochemistryPharmacology
2009English

Negative Regulation of Chemokine Receptor Signaling and B-Cell Chemotaxis by P66Shc

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy